Saturday 17 October 2026
Export ETAOF’s income statement to Excel — free account
ETAO International Co., Ltd.
ETAOF Healthcare Health Information Services
ETAO International Co., Ltd.’s revenue for fiscal 2022 (year ended December 2022) was $58.1 million. Operating cash flow growth for five consecutive years.
0.00
0.00
NaN
Follow ETAOF
Target Price Range
Analyst price targets
Free accountTen years at a glance Fiscal years to December
| Group | Line | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | Trend | 2023e | 2024e | 2025e |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Price, $ | |||||||||||||||
| Price, $ | Low | — | — | — | — | — | — | — | — | 187.40 | 194.20 |
Analyst estimates 2023–2025 Powerpack |
|||
| High | — | — | — | — | — | — | — | — | 202.60 | 210.40 | |||||
| People | |||||||||||||||
| People | Employees | — | — | — | — | — | — | — | — | 1 | 3,600 | ||||
| Revenue/emp, $m | — | — | — | — | — | — | — | — | 53.34 | 0.02 | |||||
| Income, $m | |||||||||||||||
| Income, $m | Revenue | — | — | — | — | — | — | — | — | 53 | 58 | ||||
| Gross margin, % | — | — | — | — | — | — | — | — | 30.49 | 32.72 | |||||
| EBT | — | — | — | — | — | — | — | — | (9) | (896) | |||||
| EBT margin, % | — | — | — | — | — | — | — | — | (17.71) | (1,543.81) | |||||
| Net income | — | — | — | — | 0 | — | — | — | (10) | (897) | |||||
| Depreciation | — | — | — | — | — | — | — | — | 2 | 2 | |||||
| Per share, $ | |||||||||||||||
| Per share, $ | Revenue | — | — | — | — | — | — | — | — | 10.67 | 11.61 | ||||
| Earnings | — | — | — | — | — | — | — | — | (2.86) | (179.40) | |||||
| Cash flow | — | — | — | — | — | — | — | — | (0.05) | 2.16 | |||||
| Capex | — | — | — | — | — | — | — | — | (0.47) | (0.13) | |||||
| Free cash flow | — | — | — | — | — | — | — | — | (0.52) | 2.04 | |||||
| Book value | — | — | — | — | — | — | — | — | 30.85 | (1.20) | |||||
| Shares, m | — | — | — | — | — | — | — | — | 5 | 5 | |||||
| Valuation, × | |||||||||||||||
| Valuation, × | P/E | — | — | — | — | — | — | — | — | 0.00 | 0.00 | ||||
| P/S | — | — | — | — | — | — | — | — | 0.00 | 0.00 | |||||
| P/B | — | — | — | — | — | — | — | — | 26.68 | 0.00 | |||||
| EV/Sales | — | — | — | — | — | — | — | — | 0.00 | 0.00 | |||||
| EV/FCF | — | — | — | — | — | — | — | — | 0.00 | 92.38 | |||||
| Cash, $m | |||||||||||||||
| Cash, $m | Operating cash flow | — | — | — | — | — | — | — | — | 0 | 11 | ||||
| Capex | — | — | — | — | — | — | — | — | (2) | (1) | |||||
| Free cash flow | — | — | — | — | — | — | — | — | (3) | 10 | |||||
| Balance, $m | |||||||||||||||
| Balance, $m | Working capital | — | — | — | — | — | — | — | — | (12) | (8) | ||||
| Total debt | — | — | — | — | — | — | — | — | 0 | 1 | |||||
| Net debt | — | — | — | — | — | — | — | — | (11) | (13) | |||||
| Shareholders’ equity | — | — | — | — | — | — | — | — | 154 | (6) | |||||
| Returns, % | |||||||||||||||
| Returns, % | ROA | — | — | — | — | — | — | — | — | (7.62) | (651.90) | ||||
| ROIC | — | — | — | — | — | — | — | — | (2.36) | 0.00 | |||||
| ROE | — | — | — | — | — | — | — | — | (10.20) | (1,209.41) | |||||
Negative figures in brackets.
Fiscal years to Dec 2022 · fundamentals updated 5 Oct 2026
Charts ten years each
ETAO International Co., Ltd. vs peers in Health Information Services (Q) = latest quarter vs a year earlier
| Company | Market cap | P/E | Fwd P/E | Revenue growth (Q) | EPS growth (Q) | FCF growth (Q) | Gross margin (Q) | EBIT margin (Q) | Compare |
|---|---|---|---|---|---|---|---|---|---|
| BEAT HeartBeam, Inc. | $24.3M | — (loss-making) | — | — | n/m | −1.24% (below 0%: shrinking) | — | 0.00% | Compare |
| RNLXY Renalytix plc - Sponsored ADR | $17.2M | — (loss-making) | — | +13.73% (above 0%: growing) | n/m | +17.96% (above 0%: growing) | 19.16% | (783.91%) | Compare |
| BFRG Bullfrog AI Holdings Inc. | $9.9M | — (loss-making) | — | +2,054.00% (above 0%: growing) | n/m | −5.67% (below 0%: shrinking) | 49.63% | (658.82%) | Compare |
| ETAOF ETAO International Co., Ltd. | $9.8M | — (loss-making) | — | — | n/m | +37,595.70% (above 0%: growing) | — | 0.00% | |
| HCTI Healthcare Triangle, Inc. | $7.4M | 0.0× | — (loss-making) | +158.38% (above 0%: growing) | n/m | +67.48% (above 0%: growing) | 22.48% | (44.28%) | Compare |
| MGRX Mangoceuticals, Inc. | $7.1M | — (loss-making) | — | −59.07% (below 0%: shrinking) | n/m | +79.27% (above 0%: growing) | 64.24% | (1,501.45%) | Compare |
| HLTHQ Cue Health Inc. | $6.9M | — (loss-making) | — (loss-making) | −87.19% (below 0%: shrinking) | n/m | +50.55% (above 0%: growing) | (90.14%) | (792.13%) | Compare |
| ZCMD Zhongchao Inc. | $6.2M | — (loss-making) | — | +20.44% (above 0%: growing) | −550.00% (below 0%: shrinking) | +191.85% (above 0%: growing) | 41.67% | 0.00% | Compare |
| ACON Aclarion, Inc. | $5.6M | — (loss-making) | — (loss-making) | +30.57% (above 0%: growing) | n/m | −41.41% (below 0%: shrinking) | 32.94% | (11,506.75%) | Compare |
| Median of peers | $7.3M | — | — | +20.44% | — | +34.25% | 32.94% | (721.36%) |
ETAO International Co., Ltd. (ETAOF) key facts
- ETAO International Co., Ltd. (ETAOF) is a Health Information Services company in the Healthcare sector.
- ETAO International Co., Ltd.’s revenue for fiscal 2022 (year ended December 2022) was $58.1 million.
- Return on equity was −1,209.4% and debt-to-equity 0.86.
- Its Altman Z-score is −58.66 (distress zone) for fiscal 2022.